Inside the medicine cabinet: making children's medicines a grown-up issue

Pamela W Barnes1

  • 1Elizabeth Glaser Pediatric AIDS Foundation, 1140 Connecticut Avenue NW, Suite 200, Washington, District of Columbia 20036, USA. pedmed@pedaids.org

Insights

Children require specialized medicines, but many drugs lack pediatric data, especially antiretrovirals for pediatric HIV/AIDS. Global efforts must improve access to safe and effective pediatric medications, particularly in underserved regions.

Area of Science:

  • Pediatric pharmacology
  • Global health equity
  • Antiretroviral drug development

Background:

  • Most medicines lack specific pediatric formulation and clinical data.
  • Children, especially those with HIV/AIDS, face limited access to appropriate drugs.
  • Existing pediatric drug testing laws show recent improvements but are insufficient.

Purpose of the Study:

  • To highlight the critical need for pediatric-specific medicines.
  • To emphasize the disparities in access to antiretroviral drugs for children with HIV/AIDS.
  • To advocate for enhanced global access to pediatric AIDS medicines.

Main Methods:

  • Review of current pediatric drug formulation and testing regulations.
  • Analysis of access to antiretroviral drugs for pediatric HIV/AIDS.
  • Examination of global disparities in pediatric medicine availability.

Main Results:

  • Significant lack of pediatric-tested and approved medications across therapeutic areas.
  • Severe limitations in access to pediatric antiretroviral therapies for HIV/AIDS.
  • Disproportionate impact on children in resource-poor countries.

Conclusions:

  • Urgent need for increased development and approval of pediatric-specific drugs.
  • Policy and regulatory enhancements are crucial for pediatric drug access.
  • Global collaboration is essential to ensure equitable access to lifesaving medicines for children, particularly those with HIV/AIDS.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...